FR3098394B1 - Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait - Google Patents

Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait Download PDF

Info

Publication number
FR3098394B1
FR3098394B1 FR1907861A FR1907861A FR3098394B1 FR 3098394 B1 FR3098394 B1 FR 3098394B1 FR 1907861 A FR1907861 A FR 1907861A FR 1907861 A FR1907861 A FR 1907861A FR 3098394 B1 FR3098394 B1 FR 3098394B1
Authority
FR
France
Prior art keywords
yeast
malassezia
oxazoline
composition
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1907861A
Other languages
English (en)
Other versions
FR3098394A1 (fr
Inventor
Stéphanie Brédif
Sophie Leclere-Bienfait
David Durancet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Expanscience SA
Original Assignee
Laboratoires Expanscience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Expanscience SA filed Critical Laboratoires Expanscience SA
Priority to FR1907861A priority Critical patent/FR3098394B1/fr
Priority to EP20737053.7A priority patent/EP3996674A1/fr
Priority to US17/624,692 priority patent/US20220249446A1/en
Priority to PCT/EP2020/069799 priority patent/WO2021009142A1/fr
Publication of FR3098394A1 publication Critical patent/FR3098394A1/fr
Application granted granted Critical
Publication of FR3098394B1 publication Critical patent/FR3098394B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

La présente invention porte sur une composition comprenant au moins une oxazoline, telle que l’OX100, permettant d’inhiber la croissance de levure du genre Malassezia et/ou de prévenir et/ou de traiter les affections causées par la levure Malassezia, les dermites séborrhéiques, les croûtes de lait, le Malassezia folliculitis, les pellicules, le pityriasis versicolor ou encore le pityriasis capitis. La présente invention porte également sur une composition comprenant au moins une oxazoline telle que l’OX100, au moins un composé tel que le diester d’acide malique et un oléodistillat d’huile végétale et/ou l’arabinogalactane, ainsi que sur son utilisation pour prévenir et/ou traiter notamment les affections causées par la levure Malassezia, les dermites séborrhéiques, les croûtes de lait, le Malassezia folliculitis, les pellicules, le pityriasis versicolor ou encore le pityriasis capitis.
FR1907861A 2019-07-12 2019-07-12 Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait Active FR3098394B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1907861A FR3098394B1 (fr) 2019-07-12 2019-07-12 Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait
EP20737053.7A EP3996674A1 (fr) 2019-07-12 2020-07-13 Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre malassezia impliquée notamment dans les croûtes de lait
US17/624,692 US20220249446A1 (en) 2019-07-12 2020-07-13 Composition Comprising at Least One Oxazoline for Inhibiting the Growth of Malassezia Yeasts Involved in Cradle Cap, in Particular
PCT/EP2020/069799 WO2021009142A1 (fr) 2019-07-12 2020-07-13 Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre malassezia impliquée notamment dans les croûtes de lait

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1907861A FR3098394B1 (fr) 2019-07-12 2019-07-12 Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait
FR1907861 2019-07-12

Publications (2)

Publication Number Publication Date
FR3098394A1 FR3098394A1 (fr) 2021-01-15
FR3098394B1 true FR3098394B1 (fr) 2022-07-08

Family

ID=68501755

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1907861A Active FR3098394B1 (fr) 2019-07-12 2019-07-12 Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait

Country Status (4)

Country Link
US (1) US20220249446A1 (fr)
EP (1) EP3996674A1 (fr)
FR (1) FR3098394B1 (fr)
WO (1) WO2021009142A1 (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769398A (en) * 1970-05-25 1973-10-30 Colgate Palmolive Co Polyethylenimine shampoo compositions
US4876249A (en) 1987-01-12 1989-10-24 Rajadhyaksha Vithal J Compositions and method comprising heterocyclic compounds containing two heteroatoms
FR2834216B1 (fr) * 2001-12-27 2004-04-30 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
JP2006160623A (ja) * 2004-12-03 2006-06-22 Taiyo Kagaku Co Ltd 抗アトピー性皮膚炎組成物
FR2885128B1 (fr) 2005-04-27 2007-07-06 Expanscience Laboratoires Sa Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant
WO2013121449A1 (fr) * 2012-02-17 2013-08-22 Epitech Group S.R.L. Compositions et procédés pour la modulation d'amidases spécifiques pour des n-acyléthanolamines en vue d'une utilisation dans la thérapie contre les maladies inflammatoires
KR101510595B1 (ko) * 2013-10-24 2015-04-09 서울대학교산학협력단 유제놀을 유효성분으로 함유하는 아토피성 피부염의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
FR3098394A1 (fr) 2021-01-15
US20220249446A1 (en) 2022-08-11
EP3996674A1 (fr) 2022-05-18
WO2021009142A1 (fr) 2021-01-21

Similar Documents

Publication Publication Date Title
MA41072A1 (fr) Nouvelles protéines spécifiques de la pyoverdine et de la pyochéline
MA52492B1 (fr) Composés inhibiteurs de rip1, procédés de préparation et d'utilisation associés
MA45811A (fr) Méthodes et compositions de traitement de maladie.
MA40661B1 (fr) Compositions d'additifs thermoassociatifs dont l'association est controlee et compositions lubrifiantes les contenant
MA35012B1 (fr) Composition phytosanitaire comprenant des huiles essentielles renforçant l'activité anti-fongique
EA202190073A1 (ru) Композиции и способы лечения видов гемоглобинопатии и талассемии
MA35456B1 (fr) Procède de traitement fongicide et/ou bactéricide de souches résistantes au moyen d'huile(s) essentielle(s)
MA41238A (fr) Dérivés 5-[(pipérazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione en tant qu'inhibiteurs d'adamts pour le traitement de l'ostéoarthrit
MA38410A1 (fr) Composés d'azétidinyloxyphénylpyrrolidine
MA31161B1 (fr) Mélanges fongicides d'anilides de l'acide 1-méthylpyrazol-4-yl carboxylique et d'azolopyrimidinylamines
MA39927B1 (fr) Inhibiteurs de glyt1 pour le traitement de troubles hématologiques
MX2020003216A (es) La composicion que comprende aceite vegetal, una fuente de acidos organicos, compuestos fenolicos y aminoacidos.
MA34583B1 (fr) Traitement fongicide bactéricide et/ou antioxydant des denrées alimentaires par application de formulations comprenant une huile essentielle et un dialkylène glycol
MX2022007670A (es) Compuestos antihelminticos que comprenden una estructura de quinolina.
FR3098394B1 (fr) Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait
PH12018501990A1 (en) Fungicidal composition
FR2999924B1 (fr) Association d'actifs comprenant au moins une huile essentielle, une cyclodextrine et un corps gras liquide et composition la contenant.
CA3010106A1 (fr) Sels de molybdate binucleaire contenant du soufre et de l'imidazolium comme additifs lubrifiants
MA37880B1 (fr) Formulation transdermique contenant des inhibiteurs de cox
FR3086943B1 (fr) Copolymere d'ethylene et de beta-farnesene
MX2022005084A (es) Formas sólidas de un modulador del receptor s1p a.
MX2021012326A (es) Nuevos compuestos de oxidazol para controlar o prevenir hongos fitopatogenicos.
FR3070396B1 (fr) Utilisation d'un melange d'esters d'acides gras a titre de cire pour bougie solide
FR3071496B1 (fr) Glyceride mixte d'acide formique, composition comprenant au moins un tel glyceride mixte, procede de preparation et utilisations
FR3103106B1 (fr) Extrait liquide aqueux de Spiruline pour la prévention et/ou le traitement des neuropathies périphériques chimio-induites et leurs symptômes, composition et utilisation correspondantes.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210115

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5